Patents Assigned to Corporacion Medichem, S.L.
  • Crystalline salt forms of a 5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine derivative
    Patent number: 8389724
    Abstract: This invention provides a novel crystalline sitagliptin ethanedisulfonate salt having the structure set forth below, and a method for using same to treat type 2 diabetes.
    Type: Grant
    Filed: March 29, 2012
    Date of Patent: March 5, 2013
    Assignee: Corporacion Medichem, S.L.
    Inventors: Stephen Benedict David Winter, Monica Benito Velez, Ernesto Duran Lopez
  • Process for the Synthesis of Solifenacin
    Publication number: 20100029944
    Abstract: This invention provides improved methods for making solifenacin and pharmaceutically acceptable salts thereof. The instant methods are unexpectedly advantageous in their simplicity and efficiency.
    Type: Application
    Filed: November 20, 2007
    Publication date: February 4, 2010
    Applicant: Corporacion Medichem, S.L.
    Inventors: Jordi Puig, Laura Sanchez, Ester Masllorens, Ignasi Auger, Jordi Bosch